Literature DB >> 5332590

Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications.

S E Epstein, E Braunwald.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 5332590     DOI: 10.1056/NEJM196611172752006

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  26 in total

1.  Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.

Authors:  P Rocha; M Guerret; D David; X Marchand; J C Kahn
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

2.  Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina.

Authors:  S Wieshammer; M Hetzel; U Barnikel; M Höher; H Seibold; M Kochs; V Hombach
Journal:  Klin Wochenschr       Date:  1991-09-16

3.  Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose.

Authors:  A S Westheim; C C Christensen; J Kjekshus
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

4.  Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.

Authors:  M Picca; F Azzollini; A Cereda; G Pelosi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.

Authors:  G Sandler; A C Pistevos
Journal:  Br Med J       Date:  1971-01-30

6.  Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.

Authors:  R F Alvares; J F Goodwin
Journal:  Br Heart J       Date:  1982-09

7.  Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.

Authors:  A Aubert; G Nyberg; R Slaastad; L Tjeldflaat
Journal:  Br Med J       Date:  1970-01-24

8.  Effects of (plus or minus)-propranolol, (plus or minus)-,(plus)-, and (minus)-alprenolol on unanaesthetized dogs with ventricular arrhythmias resulting from coronary artery ligation.

Authors:  B R Duce; L Garberg; E R Smith
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  Clinical experience with dextro-alprenolol.

Authors:  J K Vohra; P L Thompson; J G Sloman
Journal:  Br Med J       Date:  1970-03-28

10.  Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.

Authors:  J F De Plaen; A Amery; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.